Therapy in primary mediastinal B-cell lymphoma.

@article{Wilson2013TherapyIP,
  title={Therapy in primary mediastinal B-cell lymphoma.},
  author={Wyndham H. Wilson and Cliona Grant and Kieron Dunleavy},
  journal={The New England journal of medicine},
  year={2013},
  volume={369 3},
  pages={282}
}
To the Editor: Dunleavy et al. (April 11 issue)1 had exceptional survival rates when treating adults with primary mediastinal large-B-cell lymphoma with dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine and prednisone plus rituximab (DA-EPOCH-R), without radiotherapy. The biologic characteristics of the disease in children are similar to those of the disease in adults.2 Regimens (without rituximab) that have been effective in the treatment of children with other mature… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.

Indian journal of pediatrics • 2017
View 4 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 12 references

The outcome of primary mediastinal large B - cell lymphoma ( PMBL ) in the R - CHOP treatment era

KJ Savage, PR Yenson, T Shenkier
Blood • 2012

The outcome of primary mediastinal large B-cell lymphoma (PMBL) in the R-CHOP treatment era. Blood 2012;120:303

KJ Savage, PR Yenson, T Shenkier
2012

Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim.

Annals of oncology : official journal of the European Society for Medical Oncology • 2008

Similar Papers

Loading similar papers…